Method for retinal gene repair in neonatal mouse

Area of Science:

• Genetics
• Molecular Biology
• Ophthalmology

Background:

• Gene correction at the mutation site offers a definitive cure for genetic diseases, unlike traditional gene augmentation.
• Oligonucleotide (ODN)-mediated gene repair utilizes cellular machinery to correct specific DNA sequences, avoiding risks of viral vectors.
• The eye is an ideal target for gene repair due to its accessibility and the potential for significant therapeutic effects with minimal repair levels.

Purpose of the Study:

• To detail an optimized method for delivering active ODNs to photoreceptor nuclei in neonatal mice.
• To describe experimental techniques for assessing treatment outcomes in retinal degeneration models.

Main Methods:

• Utilized saline transpalpebral iontophoresis for targeted ODN delivery to the eye surface.
• Combined iontophoresis with intravitreous ODN injection for enhanced nuclear targeting.
• Employed neural retina dissection, immunolabeling, and flat-mounting for photoreceptor survival analysis.

Main Results:

• The described method effectively targets ODNs to photoreceptor nuclei in a neonatal mouse model.
• Photoreceptor survival, a key indicator of therapeutic efficacy, can be directly observed using the established techniques.
• This approach provides a foundation for evaluating gene repair strategies for inherited retinal diseases.

Conclusions:

• Oligonucleotide-mediated gene repair presents a precise and potentially safer alternative for genetic disease treatment.
• The optimized delivery and assessment methods are crucial for advancing gene repair therapies for ocular conditions.
• This study provides a robust framework for future research into correcting genetic defects in the retina.